- Home
- ALT vs API Comparison
ALT vs API Comparison
Compare ALT & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | API |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 339.0M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALT | API |
|---|---|---|
| Price | $2.91 | $4.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 274.3K |
| Earning Date | 05-08-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | $13.46 |
| Revenue Next Year | N/A | $12.87 |
| P/E Ratio | ★ N/A | $92.30 |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $3.14 |
| 52 Week High | $6.44 | $5.50 |
Technical Indicators
Market Signals| Indicator | ALT | API |
|---|---|---|
| Relative Strength Index (RSI) | 50.38 | 45.57 |
| Support Level | $2.87 | $3.73 |
| Resistance Level | $3.09 | $4.01 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 30.36 | 24.55 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.